Neuropsychological effects of epilepsy and antiepileptic drugs
暂无分享,去创建一个
[1] G. Pledger,et al. A Multicenter, Randomized Clinical Study to Evaluate the Effect on Cognitive Function of Topiramate Compared with Valproate as Add‐On Therapy to Carbamazepine in Patients with Partial‐Onset Seizures , 2000, Epilepsia.
[2] A. Aldenkamp,et al. Cognitive effects of a new pyrrolidine derivative (levetiracetam) in patients with epilepsy , 1995, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[3] M. Trimble,et al. Vigabatrin and psychosis. , 1991, Journal of neurology, neurosurgery, and psychiatry.
[4] C. Dodrill,et al. Effects of Differing Dosages of Vigabatrin (Sabril) on Cognitive Abilities and Quality of Life in Epilepsy , 1995, Epilepsia.
[5] D. Andrewes,et al. Degree of left hippocampal atrophy correlates with severity of neuropsychological deficits , 1997, Seizure.
[6] M. Brodie,et al. A double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy with health-related quality of life as an outcome measure , 2000, Seizure.
[7] W. Lennox. BRAIN INJURY, DRUGS, AND ENVIRONMENT AS CAUSES OF MENTAL DECAY IN EPILEPSY , 1942 .
[8] C. Dodrill,et al. Cognitive and quality of life effects of differing dosages of tiagabine in epilepsy , 1997, Neurology.
[9] K. Meador,et al. Comparative cognitive effects of phenobarbital, phenytoin, and valproate in healthy adults , 1995, Neurology.
[10] I. Fried,et al. Long‐term follow‐up after temporal lobe resection for lesions associated with chronic seizures , 1997, Neurology.
[11] O. Devinsky. Cognitive and Behavioral Effects of Antiepileptic Drugs , 1995, Epilepsia.
[12] J. Cramer,et al. Quality of life for people with epilepsy. , 1994, Neurologic clinics.
[13] K. Furusho,et al. Genetic polymorphism of the CYP2C subfamily and its effect on the pharmacokinetics of phenytoin in Japanese patients with epilepsy , 1997, Clinical pharmacology and therapeutics.
[14] S. D. Moore,et al. Seizure-like activity disrupts LTP in vitro , 1993, Neuroscience Letters.
[15] S. Shorvon,et al. Reduction in polypharmacy for epilepsy. , 1979, British medical journal.
[16] K. Meador,et al. Review: Neuropsychological Effects of Antiepileptic Drugs A Current Perspective , 1993, Clinical neuropharmacology.
[17] M. J. Brodie,et al. Drug therapy : antiepileptic drugs , 1996 .
[18] J. Hughlings Jackson,et al. CASE OF EPILEPSY WITH TASTING MOVEMENTS AND “DREAMY STATE”—VERY SMALL PATCH OF SOFTENING IN THE LEFT UNCINATE GYRUS , 1898 .
[19] M. Jokelainen,et al. Motor and cognitive functions in newly diagnosed adult seizure patients before antiepileptic medication , 2000, Acta neurologica Scandinavica.
[20] B. Bourgeois. Antiepileptic Drugs, Learning, and Behavior in Childhood Epilepsy , 1998, Epilepsia.
[21] K. Meador,et al. Comparative cognitive effects of carbamazepine and phenytoin in healthy adults , 1991, Neurology.
[22] M. Trimble. Carbamazepine and mood: evidence from patients with seizure disorders. , 1988, The Journal of clinical psychiatry.
[23] C. Elger,et al. Right hippocampal contribution to visual memory: a presurgical and postsurgical study in patients with temporal lobe epilepsy , 1998, Journal of neurology, neurosurgery, and psychiatry.
[24] C. Dodrill,et al. Neuropsychological effects of carbamazepine and phenytoin , 1991, Neurology.
[25] Simon Shorvon,et al. Multicenter Double‐Blind, Randomized, Placebo‐Controlled Trial of Levetiracetam as Add‐On Therapy in Patients with Refractory Partial Seizures , 2000 .
[26] M. Brodie,et al. New antiepileptic drugs , 1996, The New England journal of medicine.
[27] C. D. Binnie,et al. Psychological effects of subclinical epileptiform EEG discharges in children. II. General intelligence tests , 1988, Epilepsy Research.
[28] M. Trimble. 11. Epilepsy and behaviour , 1991, Epilepsy Research.
[29] F. Monaco. Cognitive effects of vigabatrin , 1996, Neurology.
[30] J. Cramer,et al. Effect of valproate on cognitive functioning. Comparison with carbamazepine. The Department of Veterans Affairs Epilepsy Cooperative Study 264 Group. , 1996, Archives of neurology.
[31] P. Kwan,et al. Early identification of refractory epilepsy. , 2000, The New England journal of medicine.
[32] J. Edinger,et al. Reversible parkinsonism and cognitive impairment with chronic valproate use , 1996, Neurology.
[33] A. Aldenkamp,et al. Memory complaints in epilepsy: correlations with cognitive performance and neuroticism , 1993, Epilepsy Research.
[34] M. Brodie,et al. Cognitive effects of anticonvulsant monotherapy in elderly patients: a placebo-controlled study , 1998, Seizure.
[35] G. Frommer,et al. Mood Change Preceding Epileptic Seizures , 1986, The Journal of nervous and mental disease.
[36] J. Engel,et al. The timing of surgical intervention for mesial temporal lobe epilepsy: a plan for a randomized clinical trial. , 1999, Archives of neurology.
[37] Colin D. Binnie,et al. The influence of subclinical epileptiform EEG discharges on driving behaviour. , 1987 .
[38] J. Fawcett. Predictors of early suicide: identification and appropriate intervention. , 1988, The Journal of clinical psychiatry.
[39] C. Binnie. Significance and management of transitory cognitive impairment due to subclinical EEG discharges in children , 1993, Brain and Development.
[40] M. Trimble,et al. Effects of Removal of Phenytoin, Carbamazepine, and Valproate on Cognitive Function , 1990, Epilepsia.
[41] A. Murro,et al. Differential Cognitive Effects of Carbamazepine and Gabapentin , 1999, Epilepsia.
[42] H. Jokeit,et al. Long term effects of refractory temporal lobe epilepsy on cognitive abilities: a cross sectional study , 1999, Journal of neurology, neurosurgery, and psychiatry.
[43] A. Aldenkamp,et al. Phenytoin and carbamazepine: Differential effects on cognitive function , 1995, Seizure.
[44] R. Bornstein,et al. Effects of seizure type and waveform abnormality on memory and attention. , 1988, Archives of neurology.
[45] J. Cramer,et al. Effect of Levetiracetam on Epilepsy‐Related Quality of Life , 2000, Epilepsia.
[46] T. Miyamoto,et al. Psychotic episodes during Zonisamide treatment , 2000, Seizure.
[47] R. Levin,et al. Psychosocial Dimensions of Epilepsy: A Review of the Literature , 1988, Epilepsia.
[48] M. Griebel,et al. Does Short‐Term Antiepileptic Drug Treatment in Children Result in Cognitive or Behavioral Changes? , 1998, Epilepsia.
[49] M. Brodie,et al. Multicentre, double-blind, randomised comparison between lamotrigine and carbamazepine in elderly patients with newly diagnosed epilepsy , 1999, Epilepsy Research.
[50] Mark S. Seidenberg,et al. Neuropsychological characteristics of the syndrome of mesial temporal lobe epilepsy. , 1997, Archives of neurology.
[51] D. Dinner,et al. Mental Deterioration in Epilepsy , 1986, Epilepsia.
[52] M. Brodie,et al. Effect of vigabatrin on sedation and cognitive function in patients with refractory epilepsy. , 1993, Journal of neurology, neurosurgery, and psychiatry.
[53] C. Polkey,et al. Relationships between neuropathology and cognitive functioning in temporal lobectomy patients. , 1987, Journal of neurology, neurosurgery, and psychiatry.
[54] M. Brodie,et al. Gabapentin and cognition: a double blind, dose ranging, placebo controlled study in refractory epilepsy. , 1997, Journal of neurology, neurosurgery, and psychiatry.
[55] E. Gibbs,et al. Epilepsy: a paroxysmal cerebral dysrhythmia , 1937, Epilepsy & Behavior.
[56] C. Dodrill,et al. Psychotropic effects of carbamazepine in epilepsy , 1977, Neurology.
[57] J. Cramer,et al. Results of a Nationwide Veterans Administration Cooperative Study Comparing the Efficacy and Toxicity of Carbamazepine, Phenobarbital, Phenytoin, and Primidone , 1987, Epilepsia.
[58] L. Provinciali,et al. Influence of vigabatrin on cognitive performances and behaviour in patients with drug‐resistant epilepsy , 1996, Acta neurologica Scandinavica.
[59] M. Brodie,et al. Double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy , 1995, The Lancet.
[60] A. Aldenkamp. Effect of Seizures and Epileptiform Discharges on Cognitive Function , 1997, Epilepsia.
[61] J. Wagner,et al. Zonisamide (CI‐912) and Cognition: Results from Preliminary Study , 1987, Epilepsia.
[62] S. Shinnar,et al. Long-term prognosis of seizures with onset in childhood. , 1998, The New England journal of medicine.
[63] David F. Smith,et al. Topiramate in clinical practice: first year’s postlicensing experience in a specialist epilepsy clinic , 1999, Journal of neurology, neurosurgery, and psychiatry.
[64] J. Cramer,et al. Behavioral Characteristics of Epilepsy Patients Compared with Normal Controls , 1986, Epilepsia.
[65] G. Baker,et al. The Stigma of Epilepsy: A European Perspective , 2000, Epilepsia.
[66] Frederick Andermann,et al. Neuroimaging evidence of progressive neuronal loss and dysfunction in temporal lobe epilepsy , 1999, Annals of neurology.
[67] C. Dodrill. Problems in the Assessment of Cognitive Effects of Antiepileptic Drugs , 1992, Epilepsia.
[68] F. Dreifuss,et al. Levetiracetam for partial seizures , 2000, Neurology.
[69] M. Brodie,et al. A double-blind, placebo-controlled interaction study between oxcarbazepine and carbamazepine, sodium valproate and phenytoin in epileptic patients. , 1994, British journal of clinical pharmacology.
[70] R. Beran,et al. Aggressive Behaviour in Intellectually Challenged Patients with Epilepsy Treated with Lamotrigine , 1998, Epilepsia.
[71] L. Gjerstad,et al. Cognitive Function and Time‐of‐Day Variation in Serum Carbamazepine Concentration in Epileptic Patients Treated with Monotherapy , 1991, Epilepsia.
[72] D. Hirtz,et al. Late Cognitive Effects of Early Treatment with Phenobarbital , 1999, Clinical pediatrics.
[73] K. Meador. Cognitive and behavioral assessments in AED trials. , 1998, Advances in neurology.
[74] R. Appleton. Treatment of childhood epilepsy. , 1995, Pharmacology & therapeutics.
[75] T. Pedley,et al. “The Scarlet E” , 2000, Neurology.
[76] O. Devinsky,et al. Behavioral changes associated with epilepsy. , 1993, Neurologic clinics.
[77] M. Trimble. Anticonvulsant Drugs and Cognitive Function: A Review of the Literature , 1987, Epilepsia.
[78] G. Avanzini,et al. Learning and Memory Impairment in Patients with Temporal Lobe Epilepsy: Relation to the Presence, Type, and Location of Brain Lesion , 1999, Epilepsia.
[79] M. Brodie,et al. Lamotrigine substitution study: evidence for synergism with sodium valproate? , 1997, Epilepsy Research.
[80] K. Meador,et al. Epilepsy, anticonvulsant drugs and cognition. , 1996, Bailliere's clinical neurology.
[81] A. Ylinen,et al. Long‐term efficacy and cognitive effects of vigabatrin , 1995, Acta neurologica Scandinavica. Supplementum.
[82] C. D. Binnie,et al. Psychological effects of subclinical epileptiform EEG discharges. I. Scholastic skills , 1988, Epilepsy Research.
[83] M. Brodie,et al. Topiramate in Refractory Epilepsy: A Prospective Observational Study , 2000, Epilepsia.
[84] C. Dodrill,et al. Effects of Tiagabine Monotherapy on Abilities, Adjustment, and Mood , 1998, Epilepsia.
[85] A. Marson,et al. Neuropsychological Outcomes in Randomized Controlled Trials of Antiepileptic Drugs: A Systematic Review of Methodology and Reporting Standards , 1998, Epilepsia.
[86] G. Baker,et al. Outcomes of Add‐on Treatment with Lamotrigine in Partial Epilepsy , 1993, Epilepsia.
[87] G. Krauss,et al. “The Scarlet E” , 2000, Neurology.
[88] M. Brodie,et al. Management of epilepsy in adolescents and adults , 2000, The Lancet.
[89] K. Meador,et al. Comparative cognitive effects of anticonvulsants , 1990, Neurology.
[90] T. Sutula,et al. Progression in mesial temporal lobe epilepsy , 1999, Annals of neurology.
[91] M. Brodie,et al. Monostars: An Aid to Choosing an Antiepileptic Drug as Monotherapy , 1999, Epilepsia.
[92] M. Trimble,et al. Anticonvulsant Drugs and Cognitive Functions , 1982, Epilepsia.
[93] S. Moshé,et al. Gabapentin Toxicity in Children Manifesting as Behavioral Changes , 1995, Epilepsia.
[94] Josemir W Sander,et al. Neuropsychological effects of tiagabine, a potential new antiepileptic drug , 1994, Seizure.
[95] R. Tallis,et al. Impact of Valproate and Phenytoin on Cognitive Function in Elderly Patients: Results of a Single‐Blind Randomized Comparative Study , 1994, Epilepsia.
[96] C D Binnie,et al. Selective cognitive impairment during focal and generalized epileptiform EEG activity. , 1984, Brain : a journal of neurology.
[97] L F Quesney,et al. Clinical and EEG Features of Complex Partial Seizures of Temporal Lobe Origin , 1986, Epilepsia.
[98] C. Dodrill,et al. Neuropsychological Abilities Before and After 5 Years of Stable Antiepileptic Drug Therapy , 1992, Epilepsia.
[99] G. Gallup,et al. A Survey of Public Attitudes Toward Epilepsy in 1974 With an Indication of Trends Over the Past Twenty‐Five Years , 1965, Epilepsia.
[100] L. Provinciali,et al. Recognition Impairment Correlated with Short Bisynchronous Epileptic Discharges , 1991, Epilepsia.
[101] Jullie W Pan,et al. Cognitive effects of topiramate, gabapentin, and lamotrigine in healthy young adults , 1999, Neurology.
[102] Simon Ball,et al. Pharmacogenetics and drug metabolism , 1997, Nature Biotechnology.
[103] R. Kälviäinen,et al. Cognitive Adverse Effects of Antiepileptic Drugs , 1996, CNS drugs.
[104] M. Brodie,et al. Cognitive function in adult epileptic patients established on anticonvulsant monotherapy , 1990, Epilepsy Research.
[105] T. Halonen,et al. Cognitive effects of oxcarbazepine and phenytoin monotherapy in newly diagnosed epilepsy: one year follow-up , 1992, Epilepsy Research.
[106] E. Somerfeld-Ziskind,et al. EFFECT OF PHENOBARBITAL ON THE MENTALITY OF EPILEPTIC PATIENTS , 1940 .
[107] C. Dodrill. Correlates of Generalized Tonic‐Clonic Seizures with Intellectual, Neuropsychological, Emotional, and Social Function in Patients with Epilepsy , 1986, Epilepsia.
[108] M. Brodie,et al. Rapid tolerance to acute psychomotor impairment with carbamazepine in epileptic patients. , 1992, British journal of clinical pharmacology.
[109] M. Brodie. Drug Interactions in Epilepsy , 1992, Epilepsia.
[110] M. Brodie,et al. Concentration-effect relationships with carbamazepine and its epoxide on psychomotor and cognitive function in epileptic patients. , 1988, Journal of neurology, neurosurgery, and psychiatry.
[111] K. Meador. Cognitive Side Effects of Antiepileptic Drugs , 1994, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.
[112] L. Lamoreaux,et al. Effect of gabapentin (neurotonin®) on mood and well-being in patients with epilepsy , 1996, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[113] M. Falconer. Reversibility by temporal-lobe resection of the behavioral abnormalities of temporal-lobe epilepsy. , 1973, The New England journal of medicine.
[114] B. Levin,et al. Cognitive outcome of children with epilepsy and malformations of cortical development , 2000, Neurology.
[115] A. Cole,et al. Early-life seizures in rats increase susceptibility to seizure-induced brain injury in adulthood , 1999, Neurology.
[116] E. Vining. Cognitive Dysfunction Associated with Antiepileptic Drug Therapy , 1987, Epilepsia.
[117] C. Dodrill. Neuropsychological aspects of epilepsy. , 1992, The Psychiatric clinics of North America.
[118] M. Trimble,et al. Effects of Vigabatrin on Cognitive Function and Mood When Used as Add‐on Therapy in Patients with Intractable Epilepsy , 1992, Epilepsia.
[119] M. Jokelainen,et al. Comparing the Cognitive Effects of Phenytoin and Carbamazepine in Long‐Term Monotherapy: A Two‐Year Follow‐Up , 1995, Epilepsia.
[120] M. Brodie,et al. Cognitive function in adult epileptic patients on long-term sodium valproate , 1991 .
[121] E. Beghi,et al. Adverse Reactions to Antiepileptic Drugs: A Multicenter Survey of Clinical Practice , 1986 .
[122] A. Kanner,et al. Positive and Negative Psychotropic Effects of Lamotrigine in Patients with Epilepsy and Mental Retardation , 1998, Epilepsia.
[123] A. Roses,et al. Pharmacogenetics and future drug development and delivery , 2000, The Lancet.
[124] H. Meinardi,et al. Reappraisal of Polytherapy in Epilepsy: A Critical Review of Drug Load and Adverse Effects , 1997, Epilepsia.
[125] M. Relling,et al. Pharmacogenomics: translating functional genomics into rational therapeutics. , 1999, Science.
[126] R. Kuzniecky,et al. Acute psychotic symptoms induced by topiramate , 1999, Seizure.
[127] G. Mawer,et al. Respiratory and sedative effects of clobazam and clonazepam in volunteers. , 1990, British journal of clinical pharmacology.
[128] I. Gamstorp,et al. A Double‐blind Study of Clonazepam in the Treatment of Therapy‐resistant Epilepsy in Children , 1977, Developmental medicine and child neurology.
[129] M. Brodie,et al. New antiepileptic drugs. , 1996, The New England journal of medicine.
[130] M. Brodie,et al. Epilepsy in elderly people , 2005, British medical journal.
[131] P. Crandall,et al. Special report. The nature of aggression during epileptic seizures. , 1981, The New England journal of medicine.
[132] K. Meador,et al. The relationship between memory performance, perceived cognitive function, and mood in patients with epilepsy , 1999, Epilepsy Research.
[133] A. Aldenkamp,et al. Cognitive side-effects of chronic antiepileptic drug treatment: A review of 25 years of research , 1995, Epilepsy Research.
[134] Theresa M. Voorhies. Cognitive and Behavioral Effects of Antiepileptic Drugs , 1988, Seminars in neurology.
[135] P. Crawford. An audit of topiramate use in a general neurology clinic , 1998, Seizure.
[136] T. S. Kerson,et al. The Depiction of Seizures in Film , 1999, Epilepsia.
[137] M. Nahata,et al. Gabapentin Associated with Aggressive Behavior in Pediatric Patients with Seizures , 1996, Epilepsia.
[138] P. Riekkinen,et al. Long-term cognitive and EEG effects of tiagabine in drug-resistant partial epilepsy , 1996, Epilepsy Research.
[139] M. Trimble,et al. Effects of gabapentin on cognition and quality of life in patients with epilepsy , 1998, Seizure.